| Aβ | Amyloid-β |
| Aβ40/42 | Amyloid-β 40 and 42 peptides |
| AD | Alzheimer’s disease |
| ANAM | Automated Neuropsychological Assessment Metrics |
| APP | Amyloid precursor protein |
| ATP | Adenosine triphosphate |
| BBB | Blood–brain barrier |
| BDNF | Brain-derived neurotrophic factor |
| BD-tau | Brain-derived tau |
| BOP | Blast overpressure |
| CAF | Canadian Armed Forces |
| CI | Credible interval |
| CMI | Cognitive–motor integration |
| CNS | Central nervous system |
| CREB | cAMP response element-binding protein |
| CSF | Cerebrospinal fluid |
| CTE | Chronic traumatic encephalopathy |
| DTI | Diffusion tensor imaging |
| EEG | Electroencephalography |
| EV | Extracellular vesicle |
| fMRI | Functional magnetic resonance imaging |
| GFAP | Glial fibrillary acidic protein |
| IL-6 | Interleukin-6 |
| IRR | Injury risk ratio (if present) |
| JNK | c-Jun N-terminal kinase |
| MAPK | Mitogen-activated protein kinase |
| MBP | Myelin basic protein |
| MCP-1 | Monocyte chemoattractant protein-1 |
| MEG | Magnetoencephalography |
| MMP | Matrix metalloproteinase |
| mBDNF | Mature BDNF |
| mTBI | Mild traumatic brain injury |
| NfL | Neurofilament light chain |
| pNF-H | Phosphorylated neurofilament heavy chain |
| NGRN | Neurogranin |
| NSE | Neuron-specific enolase |
| PET | Positron emission tomography |
| PCL | PTSD Checklist |
| PI3K | Phosphoinositide 3-kinase |
| PLCγ | Phospholipase C-gamma |
| PRDX-6 | Peroxiredoxin-6 |
| PTSD | Post-traumatic stress disorder |
| RBANS | Repeatable Battery for the Assessment of Neuropsychological Status |
| RPQ | Rivermead Post-Concussion Questionnaire |
| S100b | S100 calcium-binding protein beta |
| SOF | Special Operations Forces |
| T-tau | Total tau |
| TBI | Traumatic brain injury |
| TNF-α | Tumor necrosis factor-alpha |
| TrkB | Tropomyosin receptor kinase B |
| UCH-L1 | Ubiquitin carboxy-terminal hydrolase L1 |
| VCAM-1/ICAM-1 | Vascular/Intercellular cell adhesion molecules |
| VILIP-1 | Visinin-like protein 1 |